Davis Polk – General Electric Capital Corporation $1 Billion Preferred Stock Offering

Davis Polk advised Barclays Capital Inc., Citigroup Global Markets Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. LLC as joint book-running managers in connection with the public offering of 10,000 shares of fixed-to-floating-rate non-cumulative perpetual preferred stock, Series C by General Electric Capital Corporation (“GECC”).

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Davis Polk – Pfizer Inc. $4 Billion Notes Offering

Davis Polk advised underwriters represented by Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, Goldman, Sachs & Co. and RBS Securities Inc. in connection with the offering of $4 billion aggregate principal amount of notes issued by Pfizer Inc. The notes were offered in five tranches, one floating-rate tranche maturing in 2018 and four fixed-rate tranches maturing in 2017, 2018, 2023 and 2043.

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Davis Polk – Concur Technologies, Inc. Convertible Senior Notes Offering

Davis Polk advised Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC as representatives of the initial purchasers in connection with a Rule 144A offering by Concur Technologies, Inc. of an aggregate principal amount of $488.75 million of its 0.5% convertible senior notes due 2018, which included $63.75 million aggregate principal amount of notes from the full exercise of the initial purchasers’ over-allotment option. In addition, Davis Polk advised Deutsche Bank AG, UBS AG, Credit Suisse International and JPMorgan Chase Bank, National Association as counterparties to convertible note hedge and warrant transactions in connection with the offering.

More >>

Tags:  Davis Polk & Wardwell LLP | Silicon Valley

Davis Polk – Meritor, Inc. Concurrent Notes Offering and Cash Tender Offer

Davis Polk advised underwriters represented by Citigroup Global Markets, Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, RBS Securities Inc. and UBS Securities LLC in connection with an SEC-registered offering by Meritor, Inc. of $275 million of its 6.75% notes due 2021. Davis Polk also advised Citigroup Global Markets Inc. as the dealer manager in connection with a concurrent cash tender offer by Meritor for any and all of its outstanding 8.125% notes due 2015. A portion of the net proceeds of the above-mentioned notes offering was used to pay the tender offer consideration, and the remainder is to be used for general corporate purposes.

More >>

Tags:  Davis Polk & Wardwell LLP | New York

V&E Secures Major Trial Victory for ITOCHU International Inc. and MedSurg Specialty Devices, Inc.

Vinson & Elkins LLP played a substantial role in winning a jury trial for client ITOCHU International Inc. and its subsidiary MedSurg Specialty Devices, Inc. in a case involving a $70 million claim for breach of a distribution contract and MedSurg’s counterclaim for unpaid sales commissions. On May 31, 2013, after a nine-day trial in the U.S. District Court for the Eastern District of Pennsylvania, ITOCHU and MedSurg won a full defense verdict on plaintiff’s breach of contract claim, and MedSurg won a full award of unpaid commissions.

More >>

Tags:  Vinson & Elkins LLP